Immunic, Inc. (IMUX) เสนอผลงานที่การประชุม 10th Joint ACTRIMS-ECTRIMS Meeting - MSToronto2026 - Slideshow (NASDAQ:IMUX) 2026-10-27

Immunic, Inc. has shared a slideshow presentation from the 10th Joint ACTRIMS-ECTRIMS Meeting. The presentation offers insights into the company's progress and strategic direction within the biotechnology sector. Specific details from the presentation are expected to cover advancements in their drug development programs, potentially highlighting new data or clinical trial updates. The ACTRIMS-ECTRIMS meeting is a significant event for researchers and clinicians focused on multiple sclerosis and related inflammatory conditions. Immunic's participation underscores its commitment to advancing therapies in this area. Investors and stakeholders will be looking for information that could impact the company's future growth and market position.